Short answer: multi-cancer early detection (MCED) — also called multi-cancer detection (MCD) — blood tests look for molecular signals such as cell-free DNA methylation patterns that may suggest cancer is present. They are not FDA-approved; some (including Galleri) are available as lab-developed tests under CLIA. They do not diagnose cancer, must not replace proven screenings like mammography or colonoscopy, and a positive signal always needs diagnostic follow-up.
Marketing for these tests often emphasizes finding cancers that lack routine screening. The clinical and regulatory picture is still evolving — and the American Cancer Society is explicit that there are not yet U.S. clinical practice guidelines recommending them for general screening.[1]
Jump to section
How MCED / MCD Blood Tests Work
MCD tests analyze blood or other fluids for pieces of DNA, RNA, or proteins associated with abnormal cells.[1] One commercially available approach (Galleri) uses targeted methylation sequencing of circulating cell-free DNA and machine-learning classifiers to report a cancer signal and, when possible, a predicted tissue of origin to guide workup.[2] A positive result is a signal — not a tumor diagnosis, stage, or treatment plan.
Regulatory Status: Not FDA-Approved
ACS states that MCD tests have not been cleared or approved by the FDA; some are offered as lab-developed tests under CLIA, which allows clinicians to order them.[1] ASCO's Educational Book likewise notes that no MCED has FDA approval for multi-cancer screening, while Galleri is commercially available through the CLIA pathway ahead of definitive randomized-outcome evidence.[2] Availability is not the same thing as guideline-endorsed population screening.
Key limit: MCED tests should not replace recommended screenings for breast, cervical, colorectal, lung, and prostate cancers.[1][3]
What Guidelines and Experts Say Today
ACS reports that there are currently no clinical practice guidelines or official U.S. recommendations for using MCDs, and encourages shared decision-making that covers benefits, limits, harms, and uncertainties.[1] Proven ACS screening pathways — mammograms, colorectal screening starting at average-risk age 45, cervical screening, LDCT for eligible high-risk smokers, and informed PSA discussions — remain the evidence-based backbone.[3] ASCO authors emphasize that commercial availability has outpaced randomized evidence that MCED testing improves cancer outcomes.[2]
Positive Signals, False Positives, and False Negatives
MCD tests do not diagnose cancer. A positive result requires additional testing to confirm whether cancer is present, what type, and where.[1] ACS notes that research so far shows over half of people with positive MCD results do not have cancer on further evaluation — false positives that can drive anxiety and unnecessary procedures.[1] False negatives can create false reassurance; a negative MCED result does not replace scheduled guideline screenings or evaluation of new symptoms.[1]
Who Should Consider a Conversation — Not a DIY Diagnosis
If you are considering Galleri or a similar test, talk with a clinician about cost (often out-of-pocket), willingness to pursue diagnostic workup after a positive signal, and how the test would sit alongside — never instead of — mammography, colonoscopy/stool-based colorectal screening, cervical screening, and other indicated tests.[1][3] Treat MCED as an emerging adjunct under active study, not a one-blood-draw replacement for cancer screening medicine.
Sources
- Multi-cancer Detection (MCD) Tests — American Cancer Society cancer.org
- Multicancer Early Detection Tests at a Crossroads: Commercial Availability Ahead of Definitive Evidence — ASCO Educational Book ascopubs.org
- American Cancer Society Guidelines for the Early Detection of Cancer — American Cancer Society cancer.org
Frequently Asked Questions
Is the Galleri test FDA-approved?
No. ACS and ASCO both state that MCED/MCD tests are not FDA-approved; Galleri is available as a lab-developed test under CLIA.[1][2]
Can MCED replace my mammogram or colonoscopy?
No. ACS is clear that MCD tests should not replace recommended screenings such as mammograms and colorectal screening exams or stool tests.[1][3]
What happens if my MCED test is positive?
You need diagnostic follow-up with a clinician. A positive MCED result is not a cancer diagnosis, and false positives are common enough that ACS highlights them as a major uncertainty.[1]